SGH
ABBV icon

Schonfeld Group Holdings’s AbbVie ABBV Stock Holding History

Schonfeld Group Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-18,860
Closed -$996K – 517
2013
Q4 		$996K Buy
18,860
+8,445
+81% +$415K 0.38% 53
2013
Q3 		$466K Buy
+10,415
New +$462K 0.95% 26

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Schonfeld Group Holdings's ABBV Position: Q1 2014 in Review

Schonfeld Group Holdings sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 18,860 shares — an estimated $996K sold.

Schonfeld Group Holdings first reported a position in ABBV in Q3 2013 and held it in 2 quarters. The position peaked at $996K in Q4 2013. 1,423 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • Schonfeld Group Holdings reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 18,860 AbbVie shares in Q1 2014, an estimated $996K.
  • Schonfeld Group Holdings first reported a position in AbbVie in Q3 2013 and held it in 2 quarters.
  • Schonfeld Group Holdings's AbbVie position peaked at $996K in Q4 2013.
  • 1,423 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on Schonfeld Group Holdings's 13F filing for Q1 2014, filed 15 May 2014.